The 2-[18F]fluoro-2-deoxy-d-glucose ([18F]FDG) is the most well-known radiopharmaceutical positron emitter, in both clinical and preclinical fields. Based on a literature review of research from the last 40 years, this paper focuses on the most important aspects of [18F]FDG production and its evolution over time. Possible future perspectives of this important radiotracer are also discussed.
Historical and radiopharmaceutical relevance of [18F]FDG
Petroni D.
Primo
;Menichetti L.Secondo
;Poli M.Ultimo
2020
Abstract
The 2-[18F]fluoro-2-deoxy-d-glucose ([18F]FDG) is the most well-known radiopharmaceutical positron emitter, in both clinical and preclinical fields. Based on a literature review of research from the last 40 years, this paper focuses on the most important aspects of [18F]FDG production and its evolution over time. Possible future perspectives of this important radiotracer are also discussed.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Petroni_2020.pdf
solo utenti autorizzati
Descrizione: Historical and radiopharmaceutical relevance of [ 18F]FDG
Tipologia:
Versione Editoriale (PDF)
Licenza:
Altro tipo di licenza
Dimensione
1.31 MB
Formato
Adobe PDF
|
1.31 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
